论文部分内容阅读
目的:探讨盐酸氨溴索联合沙丁胺醇治疗支气管扩张症的临床疗效。方法:将120例支气管扩张症患者随机分为对照组与观察组,每组60例。两组均给予常规治疗,对照组在常规治疗基础上加用盐酸氨溴索治疗,观察组在常规治疗基础上给予盐酸氨溴索联合沙丁胺醇治疗,比较两组临床疗效及肺功能情况。结果:观察组与对照组治疗总有效率分别为96.7%和83.3%,观察组显著优于对照组(P<0.05);治疗后观察组PEF、FVC、FEV1优于对照组(P<0.05)。结论:盐酸氨溴索联合沙丁胺醇治疗支气管扩张症可显著提高临床疗效,改善患者肺功能。
Objective: To investigate the clinical efficacy of ambroxol combined with salbutamol in the treatment of bronchiectasis. Methods: 120 cases of bronchiectasis were randomly divided into control group and observation group, 60 cases in each group. The two groups were given routine treatment. The control group was treated with Ambroxol Hydrochloride on the basis of conventional treatment. The observation group was given ambroxol hydrochloride combined with salbutamol on the basis of routine treatment. The clinical curative effect and pulmonary function were compared between the two groups. Results: The total effective rates of the observation group and the control group were 96.7% and 83.3%, respectively, and the observation group was significantly better than the control group (P <0.05). After treatment, the PEF, FVC and FEV1 in the observation group were better than those in the control group (P <0.05) . Conclusion: Ambroxol hydrochloride combined with salbutamol in the treatment of bronchiectasis can significantly improve clinical efficacy and improve lung function.